MLH1 and diffuse type adenocarcinoma: Patient 1 was a 53-year-old man carrying the MLH1 mutation (Table 1, Figure 1) who developed an HP infection negative diffuse-type adenocarcinoma (T2N0) at the fundus (Figure 2a).